<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Because reduced <z:chebi fb="6" ids="39025">high density lipoproteins</z:chebi> may contribute to atherothrombotic <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e>, we performed molecular biologic and metabolic studies to characterize <z:chebi fb="6" ids="39025">high density lipoprotein</z:chebi> metabolism with respect to its role in reverse cholesterol transport, to clone the <z:chebi fb="6" ids="39025">high density lipoprotein</z:chebi> receptor, and to determine gene polymorphism for <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A-I, the major protein of <z:chebi fb="6" ids="39025">high density lipoprotein</z:chebi>, because altered structure may impair reverse cholesterol transport </plain></SENT>
<SENT sid="1" pm="."><plain>For <z:chebi fb="6" ids="39025">high density lipoprotein</z:chebi> metabolism measurements, <z:chebi fb="6" ids="39025">high density lipoprotein</z:chebi> 3 was isolated, purified, and labeled with <z:chebi fb="60" ids="24859">iodine</z:chebi>-125 </plain></SENT>
<SENT sid="2" pm="."><plain>The radiolabeled <z:chebi fb="6" ids="39025">high density lipoprotein</z:chebi> 3 was reinjected, and daily blood samples were taken for 10 days </plain></SENT>
<SENT sid="3" pm="."><plain>Synthesis rates and fractional catabolic rates were determined from the specific activities and daily decrements </plain></SENT>
<SENT sid="4" pm="."><plain>Preliminary data indicate that <z:hpo ids='HP_0001297'>stroke</z:hpo>-prone individuals' fractional catabolic rates for <z:chebi fb="6" ids="39025">high density lipoprotein</z:chebi> 3 are twice those of <z:mpath ids='MPATH_458'>normal</z:mpath> individuals </plain></SENT>
<SENT sid="5" pm="."><plain>Also, the conversion of <z:chebi fb="6" ids="39025">high density lipoprotein</z:chebi> 3 to <z:chebi fb="6" ids="39025">high density lipoprotein</z:chebi> 2 is reduced in these individuals, suggesting that <z:chebi fb="6" ids="39025">high density lipoprotein</z:chebi> may be abnormally processed in individuals prone to atherothrombic <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarctions</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>We surveyed more than 100 patients with <z:hpo ids='HP_0100546'>carotid stenosis</z:hpo> using a 2.2-kb probe for the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A-I gene </plain></SENT>
<SENT sid="7" pm="."><plain>A subset of these patients displays polymorphism with restriction enzymes SacI or PstI </plain></SENT>
<SENT sid="8" pm="."><plain>These preliminary findings suggest that gene polymorphism for <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A-I may provide a molecular clue of atherothrombic <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
</text></document>